Dr. Richard G. Vlasak, MD

Dr. Vlasak practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Vlasak's NPI, 1538197298, was assigned on June 29, 2006. Dr. Vlasak graduated from University Of Florida College Of Medicine in 1988. Dr. Vlasak holds Florida license ME57394.

Dr. Vlasak's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Vlasak's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Vlasak to 1 more home health agency, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vlasak practices, 3 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Vlasak's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Vlasak is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Vlasak's licenses on file in 2 states: Florida and Minnesota.

Dmand AI lists amputation, arthritis, broken or dislocated ankle/ or foot, bursitis, enthesopathy in foot or ankle, fluid in a joint, hip replacement and joint arthropathy among the conditions Dr. Vlasak treats.

CMS data shows 22,474 Medicare services from Dr. Vlasak across 12 procedure codes in 2024, for 354 Medicare patients. Medicare paid $117,339 for them.

CMS counts 354 Medicare patients who saw Dr. Vlasak in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have arthritis, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vlasak's median patient age at 73, with 55% women.

In 2024, Dr. Vlasak wrote 541 Medicare Part D claims for 162 patients. 98% of them were for generic drugs. CMS names the drug for 473 of them, across 10 drugs with 11 or more claims each, at $8,666 in total drug cost. In 2023, CMS named 535 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Vlasak for performance year 2024, reported individually. CMS counts 32 procedures of hip replacement by Dr. Vlasak, more than 77% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Upper limb (arm) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Vlasak, published from 2012 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Prosthesis Failure, Reoperation and Arthroplasty, Replacement, Hip. Dr. Vlasak has published most often in J Arthroplasty. Dr. Vlasak's most frequent co-authors are Chancellor Folsom Gray, MD, Hari Kiran Parvataneni, MD and Kalia Kumar Sadasivan, MD.

Dmand AI links Dr. Vlasak to 2 clinical trials.

CMS Open Payments shows 259 general payments to Dr. Vlasak from 6 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 99% of the total. Ortho Development Corporation paid the most, $1,279,912.

Dmand AI lists 1 award for Dr. Vlasak, most recently CMS Stage 1 EHR in 2012.

Dr. Vlasak graduated from University Of Florida College Of Medicine in 1988.

Dr. Vlasak is in network with 7 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.